Novo Nordisk chief Jørgensen to step down

Unlock the editor’s digest in free

FT editor Raula Khalaf selected his favorite stories in this weekly newsletter.

Novo Nordisk has announced that Chief Executive Lars Fruffard Zargennsen will resign just a few days after reducing the forecast for the pioneer of the obesity drugs.

The Danish Group said Friday that they had begun searching for the new CEO after the new leadership needed after Jargennsen agreed.

“In recent considerations Market challengeThe decrease in the share price and the Novo Nordisk Foundation, the Novo Nordisk Board and Lars Freureguard Georgensen jointly concluded that the CEO was best interested in the successor and its shareholders, “Novo said.

This is a developing story